Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

Obese women with PCOS are more likely to have fatty liver disease.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Spironolactone treatment increases the amount of testosterone available in the body.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Finasteride increases hair growth, prolongs hair cycle, and lowers dihydrotestosterone levels.